Corteva shares surge 5.55% after-hours as new bioinsecticide and nature-inspired insecticide announcements boost growth prospects.

Corteva surged 5.55% in after-hours trading following the announcement of two innovative crop protection solutions—Goltrevo bioinsecticide and Varpelgo active—as well as stronger-than-expected Q3 2025 financial results and raised full-year guidance. The new products, targeting sap-feeding and chewing pests with enhanced sustainability profiles, underscore the company’s focus on expanding its biologicals portfolio and addressing global crop loss challenges. Concurrently, the company reported a narrower-than-forecast net loss, $2.62 billion in sales (exceeding estimates by 5.65%), and raised 2025 operating EPS guidance to $3.25–$3.35, reflecting improved earnings momentum. These developments, coupled with management’s confidence in future growth and dividend commitments, drove investor optimism, particularly around Corteva’s innovation pipeline and near-term commercialization prospects in Latin America and Asia Pacific.